Rachael Alford
Equibles does not estimate personal net worth.
Get an email with a short summary when Yarrow Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.
Get YARW alertsAbout Rachael Alford
Rachael Alford is recorded as COO at Yarrow Bioscience, Inc. (YARW) since July 27, 2026. Yarrow Bioscience, Inc. reported in an 8-K filed July 28, 2026 that Rachael Alford was appointed Chief Operating Officer, effective July 27, 2026. Yarrow Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Yarrow Bioscience, Inc. includes Rebecca Frey (CEO and Board Member), Bill Lundberg (Chairman and Board Member), Andrew Saik (CFO) and 7 others.
“Rachael Alford, Ph.D. as the Company's Chief Operating Officer, each to serve at the discretion of the Board.”
Affiliation history
-
Current
2026-07-27–present
Company network
Leadership on record at Yarrow Bioscience, Inc.
- Rebecca Frey CEO, Board Member
- Bill Lundberg Chairman, Board Member
- Andrew Saik CFO
- Ilan Hadar CFO
- Tyler Zeronda CFO
- Iain Stuart CTO
- David Domzalski Board Member
- Dr. Christine Borowski Board Member
- Mona Ashiya Board Member
- Mona Ashiya, Ph.D. Board Member